These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 285861)

  • 41. Papilloedema in chronic granulocytic leukaemia.
    Stainsby D; Elleray E; Anderson J; Hamilton PJ; Thompson RB
    Br J Haematol; 1983 Oct; 55(2):243-9. PubMed ID: 6577908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Kinetic constants of leukocyte reduction in the course of treatment of chronic myeloleukosis with different doses of myelosan].
    Levitin EI; Kukharenko IuA; Evsenko LS; Emanuel' NM
    Izv Akad Nauk SSSR Biol; 1968; 5():739-43. PubMed ID: 5262634
    [No Abstract]   [Full Text] [Related]  

  • 43. Busulphan and melphalan prior to autologous transplantation for myeloid malignancies.
    Cony-Makhoul P; Marit G; Boiron JM; Puntous M; Reiffers J
    Bone Marrow Transplant; 1995 Jul; 16(1):69-70. PubMed ID: 7581131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C; Cruz A; Codoceo V
    Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
    [No Abstract]   [Full Text] [Related]  

  • 45. In vitro colony forming cells and colony stimulating factor in chronic granulocytic leukaemia.
    Goldman JM; Th'ng KH; Lowenthal RM
    Br J Cancer; 1974 Jul; 30(1):1-12. PubMed ID: 4528599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The treatment of chronic granulocytic leukaemia.
    Spiers AS
    Br J Haematol; 1976 Mar; 32(3):291-8. PubMed ID: 766818
    [No Abstract]   [Full Text] [Related]  

  • 47. Dibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan.
    Canellos GP; Young RC; Neiman PE; DeVita VT
    Blood; 1975 Feb; 45(2):197-203. PubMed ID: 1054609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of chronic myeloid leukemia: a five-year survey with a comparison of oral busulfan and splenic irradiation.
    Gollerkeri MP; Shah GB
    Cancer; 1971 Mar; 27(3):596-601. PubMed ID: 5279330
    [No Abstract]   [Full Text] [Related]  

  • 49. Busulphan lung in childhood.
    Oakhill A; Green ID; Knowlson GT; Cameron AH; Shah KJ; Hill FG; Mann JR
    J Clin Pathol; 1981 May; 34(5):495-500. PubMed ID: 6941971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The possibility of radical chemotherapy in chronic myelocytic leukaemia.
    Galton DA
    Haematol Lat; 1969; 12(3):703-9. PubMed ID: 5273182
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevention of blastic crisis in Ph1-positive chronic myeloid leukemia.
    Sharp JC
    Recent Results Cancer Res; 1982; 80():78-82. PubMed ID: 6949238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-dose busulphan and cyclophosphamide as the primary preparative regimen for marrow transplantation in chronic myeloid leukaemia.
    Urban EC; Kroisel P
    Bone Marrow Transplant; 1987 Aug; 2(2):217-8. PubMed ID: 3332170
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of busulfan and cyclophosphamide in the treatment of chronic myelocytic leukemia.
    Kaung DT; Close HP; Whittington RM; Patno ME
    Cancer; 1971 Mar; 27(3):608-12. PubMed ID: 4927347
    [No Abstract]   [Full Text] [Related]  

  • 54. High dose busulphan/cyclophosphamide for autologous bone marrow transplantation is associated with minimal non-hemopoietic toxicity.
    Rosenthal MA; Grigg AP; Sheridan WP
    Leuk Lymphoma; 1994 Jul; 14(3-4):279-83. PubMed ID: 7524888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutrophil function in chronic granulocytic leukaemia before and after busulphan treatment.
    Whittaker JA; Khurshid M; Hughes HR
    Br J Haematol; 1974 Dec; 28(4):541-9. PubMed ID: 4616717
    [No Abstract]   [Full Text] [Related]  

  • 56. Hydroxyurea therapy in chronic myelogenous leukemia.
    Kennedy BJ
    Cancer; 1972 Apr; 29(4):1052-6. PubMed ID: 4552811
    [No Abstract]   [Full Text] [Related]  

  • 57. Pure RBC aplasia associated with chronic granulocytic leukemia.
    Kitahara M
    JAMA; 1978 Jul; 240(4):376. PubMed ID: 275516
    [No Abstract]   [Full Text] [Related]  

  • 58. Chronic granulocytic leukaemia: clinical course, blood and bone marrow changes after chemotherapy and splenectomy.
    Spiers AS; Ermidou-Sazeidis C; Richards HG
    Haematologica; 1979 Oct; 64(5):616-34. PubMed ID: 116922
    [No Abstract]   [Full Text] [Related]  

  • 59. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
    Comhaire F; Van Hove W; Van Ganse W; Van der Straeten M
    Scand J Respir Dis; 1972; 53(5):265-73. PubMed ID: 4508954
    [No Abstract]   [Full Text] [Related]  

  • 60. Bullous eruption and elevated leukocyte alkaline phosphatase in the course of busulfan-treated chronic granulocytic leukemia.
    Dosik H; Hurewitz DJ; Rosner F; Schwartz JM
    Blood; 1970 Apr; 35(4):543-8. PubMed ID: 5266600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.